Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
pilocarpinnitrat |
Is a |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Pilocarpine adverse reaction |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine overdose |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Intentional pilocarpine overdose |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
overdosis af pilocarpin, uvist med hvilken hensigt |
Causative agent |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride (substance) |
Is a |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Pilocarpine nitrate (substance) |
Is a |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Product containing pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
physostigmin 0,25 % + pilocarpin 2 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
physostigmin 0,25 % + pilocarpin 4 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
physostigmin 0,5 % + pilocarpin 4 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Product containing physostigmine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Intentional pilocarpine poisoning |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Allergy to pilocarpine (finding) |
Causative agent |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Poisoning by pilocarpine |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpinhydrochlorid 5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Pilocarpine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpin 7,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
pilocarpin til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Accidental poisoning by pilocarpine |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Allergy to pilocarpine (finding) |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpinhydrochlorid 5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpinhydrochlorid 5 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpin 7,5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpin 7,5 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 1 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 4 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilocarpinhydrochlorid 6 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 2 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Product containing epinephrine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
Pilocarpine nitrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 5 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
pilocarpin 7,5 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Product containing only epinephrine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Product containing only physostigmine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Product containing only pilocarpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Product containing only pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
Accidental pilocarpine overdose |
Causative agent |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |